GlassScriptPhysician profile
Evann Eisenberg
NPI 1922379965
$8,028.93
in general payments reported to CMS, 2019-2025
37 companies · $1,692 in 2025
The $1,692 reported for 2025 was more than what 81% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $306 · 2021: $1,897 · 2022: $1,148 · 2023: $1,631 · 2024: $1,355 · 2025: $1,692.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,677.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,677.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,486.19 | 2021-2025 | |
| Pfizer INC. | $1,026.33 | 2021-2025 | |
| Alnylam Pharmaceuticals INC. | $701.03 | 2021-2025 | Amvuttra, Onpattro |
| Boehringer Ingelheim Pharmaceuticals, INC. | $586.45 | 2021-2025 | Jardiance |
| Amgen INC. | $558.72 | 2020-2025 | Repatha, Repatha |
| Astrazeneca Pharmaceuticals LP | $420.74 | 2020-2025 | Wainua, Farxiga |
| Abbott Laboratories | $382.41 | 2020-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems |
| Janssen Pharmaceuticals, INC | $341.04 | 2020-2024 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $238.80 | 2021-2025 | Lifevest |
| Esperion Therapeutics, INC. | $231.56 | 2020-2021 | |
| E.R. Squibb & Sons, L.L.C. | $211.62 | 2021-2025 | Eliquis, Camzyos |
| Bayer Healthcare Pharmaceuticals INC. | $176.55 | 2021-2025 | |
| Boston Scientific Corporation | $169.21 | 2021-2024 | Emblem Mri S-Icd |
| Novo Nordisk INC | $152.59 | 2021-2024 | Ozempic, Rybelsus |
| Astellas Pharma US INC | $139.15 | 2022-2023 | Lexiscan |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Evann Eisenberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.